Avanos Medical (AVNS) Net Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.32% |
| Dec 31, 2025 | 17.70% |
| Sep 30, 2025 | -19.81% |
| Jun 30, 2025 | -11.78% |
| Mar 31, 2025 | -2.59% |
| Dec 31, 2024 | 32.36% |
| Sep 30, 2024 | 41.29% |
| Jun 30, 2024 | 17.89% |
| Mar 31, 2024 | 22.10% |
| Dec 31, 2023 | 4.76% |
| Sep 30, 2023 | 17.36% |
| Jun 30, 2023 | -15.32% |
| Mar 31, 2023 | -10.47% |
| Dec 31, 2022 | -33.59% |
| Sep 30, 2022 | 4.37% |
| Jun 30, 2022 | -12.50% |
| Mar 31, 2022 | -20.31% |
| Dec 31, 2021 | -6.36% |
| Sep 30, 2021 | -16.05% |
| Jun 30, 2021 | 62.92% |
| Mar 31, 2021 | -17.78% |
| Dec 31, 2020 | -44.05% |
| Sep 30, 2020 | -140.82% |
| Jun 30, 2020 | 36.09% |
| Mar 31, 2020 | -20.95% |
| Dec 31, 2019 | -16.22% |
| Sep 30, 2019 | -56.77% |
| Jun 30, 2019 | -46.42% |
| Mar 31, 2019 | -36.06% |
| Dec 31, 2018 | -75.71% |